Role of leptin in pathogenesis of hepatic steatosis, steatohepatitis and endothelial dysfunction in obesity: literature review

Cover Page

Cite item

Full Text

Abstract

According to the latest WHO data, in the world there are 2 billion adults and 381 million children and adolescents from 0 to 19 years old, who are overweight or obese. This is due to the presence of many factors affecting the occurrence and development of this disease. One of the important links in the pathogenesis of obesity is hyperleptinemia in combination with leptin resistance.

In this article, we attempted to summarize the information on the role of leptin in the pathogenesis of obesity complications such as liver steatosis, steatohepatitis and endothelial dysfunction. Parallels have been drawn between insulin resistance and leptin resistance. The relationship of leptin and insulin was analyzed, and data on the effect of these hormones on carbohydrate and fat metabolism are also presented.

About the authors

A. M. Miftakhova

E.A. Vagner Perm State Medical University

Author for correspondence.
Email: albinamiftahova91@mail.ru

Lecturer for work with foreign students, Department of Pathological Physiology

Russian Federation, Perm

L. D. Pestrenin

E.A. Vagner Perm State Medical University

Email: albinamiftahova91@mail.ru

postgraduate student, Lecturer for work with foreign students, Department of Pathological Physiology

Russian Federation, Perm

I. L. Gulyaeva

E.A. Vagner Perm State Medical University

Email: albinamiftahova91@mail.ru

MD, PhD, Professor, Head of Department of Pathological Physiology

Russian Federation, Perm

References

  1. Obesity and overweight: World Health Organization 2020, available at: https://www. who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight
  2. Malkov P.V. Baranov Je.F., Bezborodova T.S., Bobylev S.N., Bugakova N.S., Gohberg L.M., Grigor'ev L.M. Russia in numbers. Brief statistical compilation 2019; 74 (in Russian).
  3. Mal'ceva S.M., Kubysheva O.O. Hedonistic lifestyle in a modern consumer society. Innovacionnaja jekonomika: perspektivy razvitija i sovershenstvovanija 2018; 8 (34): 237–240 (in Russian).
  4. Matosjan K.A., Oranskaja A.N., Mkrtumjan A.M., Gurevich K.G. Biochemical markers of obesity in people 18–25 years old. Kardiovaskuljarnaja terapija i profilaktika 2017; 16 (5): 34–39 (in Russian).
  5. Livzan M.A., Lapteva I.V., Miller T.S. The role of leptin and leptin resistance in the formation of non-alcoholic fatty liver disease in individuals with obesity and overweight. Jeksperimental'naja i klinicheskaja gastrojenterologija 2014; 108 (8): 27–32 (in Russian).
  6. Konstantinova E.V., Balajan N.M., Shostak N.A. Myocardial infarction in young people: causes and prognosis. Klinicist 2016/2017; 10/11: 10–15 (in Russian).
  7. Borodina C.B., Gapparova K.M., Zajnudinov Z.M., Grigor'jan O.N. Genetic predictors of obesity. Ozhirenie i metabolizm 2016; 13 (2): 7–13 (in Russian).
  8. Stepanova O.I., Karkishhenko V.N., Baranova O.V., Semenov H.H. Genetic model of type 2 diabetes on mutant line mice С57BL/KsJYLeprdb/+. Biomedicina 2009; 2: 28 (in Russian).
  9. Osipova A.A. The role of leptin in the regulation of energy metabolism and the functioning of living organisms. Okruzhajushhaja sreda i jenergovedenie 2019; 2:57–59, 63–67, 72–81 (in Russian).
  10. Chumakova G.A., Ott A.V., Veselovskaja N.G., Gricenko O.V., Shenkova N.N. Pathogenetic mechanisms of leptin resistance. Rossijskij kardiologicheskij zhurnal 2015; 4 (120): 107–110 (in Russian).
  11. Juzhakova A.E., Nelaeva A.A., Hasanova Ju.V. Development of carbohydrate metabolism disorders from the position of chronobiology. Medicinskij sovet 2018; 4: 42–47 (in Russian).
  12. Ott A.V., Chumakova G.A., Veselovskaja N.G. Leptin resistance as a significant predictor of the metabolically obese obesity phenotype. Karidologija. Terapija 2018; 8 (152): 30–35 (in Russian).
  13. Dedov I.I., Troshina E.A., Mazurina N.V., Galieva M.O., Logvinova O.V. The role of neurotransmitters in the regulation of energy homeostasis and the possibility of drug correction of its disorders in obesity. Ozhirenie i metabolizm 2016; 13 (1): 9–15 (in Russian).
  14. Riger N.A., Shipelin V.A., Aprjatin S.A., Gmoshinskij I.V. Immunological markers of alimentary-induced hyperlipidemia in Wistar rats. Voprosy pitanija 2019; 88 (3): 44–49 (in Russian).
  15. Rojtberg G.E., Dorosh Zh.V., Sharhun O.O., Ushakova T.I., Trubino E.A. Possibilities of using a new metabolic index in assessing insulin resistance in clinical practice. Racional'naja Farmakoterapija v kardiologii 2014; 10 (3): 265–273 (in Russian).
  16. Ott A.V., Chumakova G.A., Veselovskaja N.G. A resistance to leptin in development of different obesity phenotypes. Rossijskij kardiologicheskij zhurnal 2016; 4 (132): 15 (in Russian).
  17. Chubenko E.A., Beljaeva O.D., Berkovich O.A., Baranova E.I. The role of leptin in the formation of metabolic syndrome. Problemy zhenskogo zdorov'ja 2010; 1(5): 49 (in Russian).
  18. Cimmerman Ja.S. Liver fibrosis: pathogenesis, diagnostic methods, treatment prospects. Klinicheskaja farmakologija i terapija 2017; 26 (1): 54–58 (in Russian).
  19. Belousova O.N., Sirotina S.S., Jakunchenko T.I., Zhernakova N.I. Molecular and genetic mechanisms of the pathogenesis of type 2 diabetes. Nauchnye vedomosti 2015; 16: 12–17 (in Russian).
  20. Chusova N.A. The role of endothelial dysfunction in obesity. Mezhdunarodnyj studencheskij nauchnyj vestnik 2019; 5: 68–72 (in Russian).

Copyright (c) 2020 Miftakhova A.M., Pestrenin L.D., Gulyaeva I.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies